Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2010, for Altria Group, Inc., a Virginia corporation. The company operates primarily through its wholly-owned subsidiaries: Philip Morris USA Inc. (cigarettes and smokeless products), UST LLC (smokeless products and wine), and John Middleton Co. (cigars and pipe tobacco). Additionally, Altria holds a 27.2% economic and voting interest in SABMiller plc. The financial statements are unaudited and reflect the consolidation of UST, acquired in January 2009.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2010 | Six Months Ended June 30, 2009 |
|---|---|---|
| Net Revenues | $12,034 million | $11,242 million |
| Operating Income | $2,959 million | $2,868 million |
| Net Earnings (Attributable to Altria) | $1,855 million | $1,599 million |
| Diluted EPS | $0.89 | $0.77 |
| Net Cash Provided by Operating Activities | $291 million | $135 million |
| Total Debt | $12.2 billion | $12.0 billion |
| Cash and Cash Equivalents | $854 million | $1,871 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 7.0% year-over-year, driven primarily by higher pricing related to the April 2009 federal excise tax increase, partially offset by lower cigarette volumes.
- Profitability: Net earnings increased 16.0% to $1.855 billion. This was driven by higher operating income, a lower effective tax rate (29.5% vs. 37.7%), and lower interest expense, partially offset by lower earnings from the SABMiller investment.
- Segment Performance:
- Cigarettes: Operating income increased 4.3% despite a 5.9% decline in shipment volume, due to price increases and cost reductions.
- Smokeless Products: Operating income doubled (100%+ increase) due to volume growth and significantly lower exit/integration costs compared to 2009.
- Financial Services: Operating income declined 70.4% due to lower gains on asset sales compared to the prior year.
- One-Time Items: The company recorded a $169 million reduction in tax-related receivables from Kraft Foods and Philip Morris International, which was fully offset by a corresponding tax benefit. Asset impairment and exit costs were $28 million in 2010 compared to $166 million in 2009.
Guidance, Outlook, and Risks
- 2010 Guidance: In July 2010, Altria raised its full-year 2010 diluted EPS guidance to a range of $1.81 to $1.85 (previously $1.78 to $1.82). This reflects higher projected earnings from operations and net tax benefits. Adjusted diluted EPS is forecast to grow 7% to 9% over 2009.
- Dividends: The quarterly dividend was increased to $0.35 per share (2.9% increase), with an annualized rate of $1.40. The target payout ratio was raised to approximately 80% of adjusted diluted EPS.
- Key Risks and Contingencies:
- Litigation: Significant tobacco-related litigation remains pending, including "Engle progeny" cases in Florida and "Lights/Ultra Lights" class actions. Management believes an unfavorable outcome is not probable for pending tobacco cases but notes the uncertainty of litigation.
- Regulation: The company faces ongoing regulatory challenges from the FDA under the Family Smoking Prevention and Tobacco Control Act (FSPTCA), including marketing restrictions and potential new product standards.
- Tax Matters: The IRS has challenged tax benefits related to PMCC leveraged lease transactions. Altria intends to file a claim for a refund of approximately $945 million related to these transactions; if disallowed, it could materially affect earnings.
- Excise Taxes: Continued state and federal tax increases are expected to adversely impact sales volumes.
Investor Verification Checklist
- Verify the impact of the $169 million reduction in Kraft/PMI tax receivables and the corresponding tax benefit on net earnings.
- Monitor the status of the IRS challenge regarding PMCC leveraged lease tax benefits and the anticipated $945 million refund claim.
- Review the progress of "Engle progeny" litigation in Florida and the potential for adverse verdicts or settlements.
- Assess the impact of FDA regulations (FSPTCA) on marketing costs and product launch capabilities.
- Confirm the sustainability of cigarette volume declines versus price increases in the core Cigarettes segment.
- Track the integration cost savings from the UST acquisition against the projected $300 million target by end of 2011.